Dag 29 er ift måling av effekt (slik jeg skjønner det)
For øvrig:
"Patients will be randomly given Bemcentinib with standard hospital treatment or Standard hospital treatment alone.Bemcentinib comes as a 100 mg capsule (a type of pill). It is taken by mouth once a day for up to 15 days or until discharge from the hospital (whichever is first). On the first 3 days patients will receive 4 capsules (400 mg total), for the next 12 days patients will receive 2 capsules (200 mg total). Stage 1 will include about 60 people. Stage 2 will include about 126. The treatment period will last up to 15 days but may be extended to 21 days if needed.
The study will determine whether bemcentinib can lessen the symptoms of COVID-19 and/or shorten the time people with COVID-19 are ill"
